The Supreme Court Just Made It Easier for You to Get Cheaper Generic Drugs—With 1 Major Catch
The Supreme Court ruled in favor of generic drugmaker Hikma, making it harder for brand-name manufacturers to block cheaper alternative drugs. However, a pharmaceutical patent lawyer noted that the legal battle over drug patents is far from over.
Read full story →Why agriculture’s biggest challenges are no longer cyclical
Agriculture now faces permanent structural challenges from climate risks, shifting trade dynamics, ESG requirements, and changing consumer expectations rather than cyclical difficulties. These transformations are fundamentally altering how the sector operates across production, trade relationships, and regulatory compliance.
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits
Johnson & Johnson agreed to pay $5.5 billion to settle tens of thousands of lawsuits claiming its talc products caused ovarian cancer. The settlement resolves litigation that has pursued the company for years regarding baby powder and other talc-based products.
Peregrine Capital: AI conviction intact after volatile first half marked by war and oil shock
An oil price spike triggered by war in March caused significant market volatility that fully recovered by April. Peregrine Capital maintains confidence in artificial intelligence investments long-term despite investor concerns about near-term expenses of building AI infrastructure.